American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Kala Visvanathan; Rowan T. Chlebowski; Patricia Hurley; Nananda F. Col; Mary Ropka; Deborah Collyar; Monica Morrow; Carolyn Runowicz; Kathleen I. Pritchard; Karen Hagerty; Banu Arun; Judy Garber; Victor G. Vogel; James L. Wade; Powel Brown; Jack Cuzick; Barnett S. Kramer; Scott M. Lippman

doi:10.1200/JOP.0948502

American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Kala Visvanathan, Rowan T. Chlebowski, Patricia Hurley, Nananda F. Col, Mary Ropka, Deborah Collyar, Monica Morrow, Carolyn Runowicz, Kathleen I. Pritchard, Karen Hagerty, Banu Arun, Judy Garber, Victor G. Vogel, James L. Wade, Powel Brown, Jack Cuzick, Barnett S. Kramer, Scott M. Lippman

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	196-199
Number of pages	4
Journal	Journal of oncology practice
Volume	5
Issue number	4
DOIs	https://doi.org/10.1200/JOP.0948502
State	Published - Jul 2009
Externally published	Yes

ASJC Scopus subject areas

Oncology
Oncology(nursing)
Health Policy

Access to Document

10.1200/JOP.0948502

Cite this

Visvanathan, K., Chlebowski, R. T., Hurley, P., Col, N. F., Ropka, M., Collyar, D., Morrow, M., Runowicz, C., Pritchard, K. I., Hagerty, K., Arun, B., Garber, J., Vogel, V. G., Wade, J. L., Brown, P., Cuzick, J., Kramer, B. S., & Lippman, S. M. (2009). American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Journal of oncology practice, 5(4), 196-199. https://doi.org/10.1200/JOP.0948502

American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. / Visvanathan, Kala; Chlebowski, Rowan T.; Hurley, Patricia et al.
In: Journal of oncology practice, Vol. 5, No. 4, 07.2009, p. 196-199.

Research output: Contribution to journal › Review article › peer-review

Visvanathan, K, Chlebowski, RT, Hurley, P, Col, NF, Ropka, M, Collyar, D, Morrow, M, Runowicz, C, Pritchard, KI, Hagerty, K, Arun, B, Garber, J, Vogel, VG, Wade, JL, Brown, P, Cuzick, J, Kramer, BS & Lippman, SM 2009, 'American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction', Journal of oncology practice, vol. 5, no. 4, pp. 196-199. https://doi.org/10.1200/JOP.0948502

@article{3d5dd6e5c76c438f9a074d025aea660c,

title = "American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction",

author = "Kala Visvanathan and Chlebowski, {Rowan T.} and Patricia Hurley and Col, {Nananda F.} and Mary Ropka and Deborah Collyar and Monica Morrow and Carolyn Runowicz and Pritchard, {Kathleen I.} and Karen Hagerty and Banu Arun and Judy Garber and Vogel, {Victor G.} and Wade, {James L.} and Powel Brown and Jack Cuzick and Kramer, {Barnett S.} and Lippman, {Scott M.}",

year = "2009",

month = jul,

doi = "10.1200/JOP.0948502",

language = "English (US)",

volume = "5",

pages = "196--199",

journal = "Journal of oncology practice",

issn = "1554-7477",

publisher = "American Society of Clinical Oncology",

number = "4",

}

TY - JOUR

T1 - American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

AU - Visvanathan, Kala

AU - Chlebowski, Rowan T.

AU - Hurley, Patricia

AU - Col, Nananda F.

AU - Ropka, Mary

AU - Collyar, Deborah

AU - Morrow, Monica

AU - Runowicz, Carolyn

AU - Pritchard, Kathleen I.

AU - Hagerty, Karen

AU - Arun, Banu

AU - Garber, Judy

AU - Vogel, Victor G.

AU - Wade, James L.

AU - Brown, Powel

AU - Cuzick, Jack

AU - Kramer, Barnett S.

AU - Lippman, Scott M.

PY - 2009/7

Y1 - 2009/7

UR - http://www.scopus.com/inward/record.url?scp=74749098215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74749098215&partnerID=8YFLogxK

U2 - 10.1200/JOP.0948502

DO - 10.1200/JOP.0948502

M3 - Review article

AN - SCOPUS:74749098215

SN - 1554-7477

VL - 5

SP - 196

EP - 199

JO - Journal of oncology practice

JF - Journal of oncology practice

IS - 4

ER -

American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this